Portrait® 630 Spotter Wins R&D100 Award

Labcyte Inc. announced today that the Portrait 630 reagent multi-spotter has been selected by an independent panel and the editors of R&D Magazine as one of the 100 most technologically significant products introduced into the marketplace over the past year.

August 23, 2007
Sunnyvale, CA
Sunnyvale, CA, August 23, 2007 — Labcyte Inc. announced today that the Portrait 630 reagent multi-spotter has been selected by an independent panel and the editors of R&D Magazine as one of the 100 most technologically significant products introduced into the marketplace over the past year.

The Portrait 630 reagent multi-spotter uses the Labcyte acoustic droplet ejection technology to bring automated reagent deposition to the new field of MALDI tissue imaging mass spectrometry (IMS). IMS links the label-free universal detection of mass spectrometry with the spatial information of molecular histology. IMS enables discovery in protein profiling, small molecule tracking, and other applications. The Portrait 630 reagent multi-spotter provides multi-step protocols, precise drop-on-drop positioning and flexible droplet timing, to automate sequential experiments such as proteolytic digests followed by matrix deposition. The Portrait 630 system enables users to optimize reaction conditions and crystal formation for more reproducible and higher quality mass spectra.

“We are very pleased that the Portrait 630 was chosen for this award,” said Elaine J. Heron, PhD, Chief Executive Officer of Labcyte Inc., “Our development team brings tremendous expertise from diverse fields to create innovative products. This instrument will enable important discovery and growth in new markets such as imaging mass spectrometry.”

Labcyte Inc., headquartered in Sunnyvale, California, is the world leader in providing acoustic droplet ejection technology for pharmaceutical and life science applications. The award-winning Echo® 500 series liquid handlers and Portrait 630 reagent multi-spotters are used in nine of the 10 largest pharmaceutical companies, as well as in leading academic and research institutions and contract research organizations worldwide. The Labcyte acoustic droplet ejection technology has broad applications including compound management, assays, arraying, particle manufacturing, imaging mass spectrometry, and live-cell transfer. Labcyte also provides a range of unique microplate consumables. Labcyte has 28 issued U.S. patents, 3 issued European patents and additional international filings. For more information, visit www.labcyte.com